Phase I study of trametinib with neoadjuvant chemoradiation (CRT) in patients with locally advanced rectal cancers (LARC).

Authors

Christina Wu

Christina Sing-Ying Wu

Emory University, Atlanta, GA

Christina Sing-Ying Wu , Terence Marques Williams , Lai Wei , Hamida Umar , Sameh Mikhail , Kristen Keon Ciombor , Emily Chan , Anne M. Noonan , Sameek Roychowdhury , Samer S El-Dika , Somashekar Krishna , Mark Arnold , Alan Harzman , Sherif Abdel-Misih , William Cirocco , Amber Traugott , Tanios S. Bekaii-Saab , Evan John Wuthrick , Sean T McCarthy

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer–Local-Regional Disease

Clinical Trial Registration Number

NCT01740648

Citation

J Clin Oncol 35, 2017 (suppl; abstr 3612)

DOI

10.1200/JCO.2017.35.15_suppl.3612

Abstract #

3612

Poster Bd #

235

Abstract Disclosures

Similar Posters